These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34707569)

  • 1. Transforming Growth Factor Beta 1 Alters Glucose Uptake but Not Insulin Signalling in Human Primary Myotubes From Women With and Without Polycystic Ovary Syndrome.
    McIlvenna LC; Patten RK; McAinch AJ; Rodgers RJ; Stepto NK; Moreno-Asso A
    Front Endocrinol (Lausanne); 2021; 12():732338. PubMed ID: 34707569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome.
    McIlvenna LC; Altıntaş A; Patten RK; McAinch AJ; Rodgers RJ; Stepto NK; Barrès R; Moreno-Asso A
    J Physiol; 2022 Jul; 600(14):3313-3330. PubMed ID: 35760527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.
    Corbould A; Kim YB; Youngren JF; Pender C; Kahn BB; Lee A; Dunaif A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1047-54. PubMed ID: 15613682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome.
    Moreno-Asso A; Altıntaş A; McIlvenna LC; Patten RK; Botella J; McAinch AJ; Rodgers RJ; Barrès R; Stepto NK
    J Mol Endocrinol; 2021 Dec; 68(1):63-76. PubMed ID: 34752415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is not conserved in myotubes established from women with PCOS.
    Eriksen M; Pørneki AD; Skov V; Burns JS; Beck-Nielsen H; Glintborg D; Gaster M
    PLoS One; 2010 Dec; 5(12):e14469. PubMed ID: 21209881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
    Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).
    Dunaif A; Wu X; Lee A; Diamanti-Kandarakis E
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E392-9. PubMed ID: 11440917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome.
    Hansen SL; Svendsen PF; Jeppesen JF; Hoeg LD; Andersen NR; Kristensen JM; Nilas L; Lundsgaard AM; Wojtaszewski JFP; Madsbad S; Kiens B
    J Clin Endocrinol Metab; 2019 May; 104(5):1841-1854. PubMed ID: 30544235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
    Austin RL; Rune A; Bouzakri K; Zierath JR; Krook A
    Diabetes; 2008 Aug; 57(8):2066-73. PubMed ID: 18443205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture Mimics Exercise-Induced Changes in Skeletal Muscle Gene Expression in Women With Polycystic Ovary Syndrome.
    Benrick A; Pillon NJ; Nilsson E; Lindgren E; Krook A; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2020 Jun; 105(6):2027-41. PubMed ID: 32232327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
    Johansson J; Feng Y; Shao R; Lönn M; Billig H; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E551-9. PubMed ID: 20663984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired enhancement of insulin action in cultured skeletal muscle cells from insulin resistant type 2 diabetic patients in response to contraction using electrical pulse stimulation.
    Al-Bayati A; Brown A; Walker M
    J Diabetes Complications; 2019 Dec; 33(12):107412. PubMed ID: 31575461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming growth factor β signalling molecules and their correlations with genes in loci linked to polycystic ovary syndrome in human foetal and adult tissues.
    Azumah R; Hummitzsch K; Anderson RA; Rodgers RJ
    Reprod Fertil Dev; 2024 Jun; 36():. PubMed ID: 38894494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising hyperinsulinemia-induced insulin resistance in human skeletal muscle cells.
    Turner MC; Martin NRW; Player DJ; Ferguson RA; Wheeler P; Green CJ; Akam EC; Lewis MP
    J Mol Endocrinol; 2020 Apr; 64(3):125-132. PubMed ID: 31990657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.